Scarlet

 430 mg Capsule
Purnava Limited
Unit Price: ৳ 27.00 (5 x 6: ৳ 810.00)
Strip Price: ৳ 162.00
Indications
  • Menopausal Symptoms:
    Used to alleviate vasomotor symptoms such as hot flashes and night sweats associated with menopause.
  • Osteoporosis Prevention:
    Investigational use for maintenance of bone density in postmenopausal women.
  • Cardiovascular Health:
    Potential adjunct in improving arterial elasticity and lipid profiles, though evidence is limited.
  • Skin Conditions:
    Traditional use topically for eczema, psoriasis, and wound healing.
  • Off-label/Traditional Uses:
    • Respiratory conditions such as whooping cough and bronchitis.
    • Detoxification and blood purification in herbal medicine practices.
Dosage & Administration
  • Adults:
    • Oral preparations (extracts standardized to isoflavones) typically dosed at 40–80 mg of isoflavones daily, divided into 2–3 doses.
    • Dried herb infusions: 2–3 grams of dried herb steeped in hot water, 2–3 times daily.
  • Pediatrics:
    Not recommended due to lack of safety data.
  • Elderly:
    Same dosing as adults; caution advised due to potential interactions.
  • Special Populations:
    No specific dose adjustments established for renal or hepatic impairment.
  • Administration:
    Oral ingestion preferred; topical formulations used as directed.
Mechanism of Action (MOA)

Red Clover contains high levels of isoflavones such as genistein, daidzein, biochanin A, and formononetin, which are phytoestrogens structurally similar to endogenous estrogens. These compounds selectively bind to estrogen receptors (ER), preferentially ER-beta, modulating gene expression and exerting estrogen-like effects that may alleviate menopausal symptoms and impact bone metabolism. Additionally, isoflavones possess antioxidant properties and may inhibit tyrosine kinases involved in cell proliferation, contributing to cardiovascular and skin benefits.

Pharmacokinetics
  • Absorption:
    Isoflavones from Red Clover are absorbed in the gastrointestinal tract; bioavailability varies based on gut microbiota activity.
  • Distribution:
    Distributed systemically; crosses biological membranes including the blood-brain barrier to exert central effects.
  • Metabolism:
    Hepatically metabolized primarily via phase II conjugation (glucuronidation, sulfation).
  • Half-life:
    Isoflavone metabolites have plasma half-lives ranging from 6 to 8 hours.
  • Excretion:
    Mainly via urine as conjugated metabolites.
Pregnancy Category & Lactation
  • Pregnancy:
    Not recommended during pregnancy due to potential estrogenic effects and lack of safety data.
  • Lactation:
    Safety unknown; caution advised as phytoestrogens may affect hormone-sensitive development in infants.
Therapeutic Class
  • Herbal supplement; phytoestrogen.
Contraindications
  • Known hypersensitivity to Red Clover or related legumes.
  • Hormone-sensitive cancers (breast, uterine, ovarian).
  • Active thromboembolic disorders or history thereof.
  • Pregnancy and breastfeeding.
Warnings & Precautions
  • Use cautiously in patients with estrogen-dependent tumors.
  • May increase risk of bleeding; avoid in patients on anticoagulants without medical supervision.
  • Potential interaction with hormone replacement therapy or hormonal contraceptives.
  • Monitor for allergic reactions, particularly in patients with legume allergies.
Side Effects
  • Common:
    Mild gastrointestinal upset, headache, rash, photosensitivity.
  • Rare:
    Hypersensitivity reactions, breast tenderness, changes in menstrual bleeding patterns.
  • Side effects are generally mild and reversible upon discontinuation.
Drug Interactions
  • May potentiate the effects of anticoagulants (e.g., warfarin), increasing bleeding risk.
  • Possible additive estrogenic effects with hormone therapies, potentially affecting efficacy.
  • No significant interactions with food or alcohol reported.
Recent Updates or Guidelines
  • Clinical guidelines cautiously recognize Red Clover as a complementary option for mild menopausal symptoms but do not recommend it as a first-line therapy due to limited robust evidence.
  • Recent meta-analyses show variable efficacy; ongoing research continues to evaluate long-term safety and impact on breast tissue.
  • Regulatory bodies advise caution in patients with hormone-sensitive conditions.
Storage Conditions
  • Store in a cool, dry place at 15°C to 25°C (59°F to 77°F).
  • Protect from light and moisture.
  • Keep container tightly closed.
  • Avoid exposure to excessive heat or humidity.
Available Brand Names

No other brands available